First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study von Lenz, Heinz-Josef, Van Cutsem, Eric, Luisa Limon, Maria, Wong, Ka Yeung Mark, Hendlisz, Alain, Aglietta, Massimo, García-Alfonso, Pilar, Neyns, Bart, Luppi, Gabriele, Cardin, Dana B, Dragovich, Tomislav, Shah, Usman, Abdullaev, Sandzhar, Gricar, Joseph, Ledeine, Jean-Marie, Overman, Michael James, Lonardi, Sara

Volltext

Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma von Kakadia, Sunilkumar, Yarlagadda, Naveen, Awad, Ramez, Kundranda, Madappa, Niu, Jiaxin, Naraev, Boris, Mina, Lida, Dragovich, Tomislav, Gimbel, Mark, Mahmoud, Fade

Volltext

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials von Desai, Aakash, Gainor, Justin F., Hegde, Aparna, Schram, Alison M., Curigliano, Giuseppe, Pal, Sumanta, Liu, Stephen V., Halmos, Balazs, Groisberg, Roman, Grande, Enrique, Dragovich, Tomislav, Matrana, Marc, Agarwal, Neeraj, Chawla, Sant, Kato, Shumei, Morgan, Gilberto, Kasi, Pashtoon M., Solomon, Benjamin, Loong, Herbert H., Park, Haeseong, Choueiri, Toni K., Subbiah, Ishwaria M., Pemmaraju, Naveen, Subbiah, Vivek

Volltext

Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127 von DRAGOVICH, Tomislav, MCCOY, Sheryl, ABBRUZZESE, James L, FENOGLIO-PREISER, Cecilia M, JIANG WANG, BENEDETTI, Jacqueline K, BAKER, Amanda F, HACKETT, Christopher B, URBA, Susan G, ZANER, Ken S, BLANKE, Charles D

Volltext

Nivolumab (NIVO) + low-dose ipilimumab (IPI) as first-line (1L) therapy in microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC... von Lenz, Heinz-Josef, Lonardi, Sara, Zagonel, Vittorina, Van Cutsem, Eric, Limon, M. Luisa, Wong, Mark, Hendlisz, Alain, Aglietta, Massimo, Garcia-Alfonso, Pilar, Neyns, Bart, Gelsomino, Fabio, Cardin, Dana Backlund, Dragovich, Tomislav, Shah, Usman, Yang, Jing, Ledeine, Jean-Marie, Overman, Michael J.

Volltext

Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials von Desai, Aakash, Gainor, Justin F., Hegde, Aparna, Schram, Alison M., Curigliano, Giuseppe, Pal, Sumanta, Liu, Stephen V., Halmos, Balazs, Groisberg, Roman, Grande, Enrique, Dragovich, Tomislav, Matrana, Marc, Agarwal, Neeraj, Chawla, Sant, Kato, Shumei, Morgan, Gilberto, Kasi, Pashtoon M., Solomon, Benjamin, Loong, Herbert H., Park, Haeseong, Choueiri, Toni K., Subbiah, Ishwaria M., Pemmaraju, Naveen, Subbiah, Vivek

Volltext

Stability of Phosphoprotein as a Biological Marker of Tumor Signaling von BAKER, Amanda F, DRAGOVICH, Tomislav, IHLE, Nathan T, WILLIAMS, Ryan, FENOGLIO-PREISER, Cecilia, POWIS, Garth

Volltext

Thrombotic Thrombocytopenic Purpura due to Checkpoint Inhibitors von Mahmoud, Fade, Dragovich, Tomislav, Stanek, Michael, Torloni, Antonio Sergio, Kasso, Nawara, Youssef, Alexey, Gimbel, Mark

Volltext

Durable and Complete Response to Herceptin Monotherapy in Patients with Metastatic Gastroesophageal Cancer von Swofford, Brenen P., Dragovich, Tomislav

Volltext

Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept von Dragovich, Tomislav, Campen, Christopher

Volltext

Sigmoid Adenocarcinoma with Regional Scrotal Metastasis von Swofford, Brenen P., Dragovich, Tomislav

Volltext

634 EVEREST-1: A seamless phase 1/2 study of CEA logic-gated Tmod CAR T-cell therapy (A2B530) in patients with solid tumors associated with CEA expression also exhibiting HLA loss... von Punekar, Salman R, Welling, Theodore, Randolph Hecht, J, Molina, Julian, Smith, Caleb, Garon, Edward, Pia Morelli, M, Fakih, Marwan, Kirtane, Kedar, Grierson, Patrick M, Patel, Sandip P, Lin, Yi, Kopetz, Scott, Locke, Frederick L, Ward, Jeffrey, Lozac’hmeur, Ariane, Frigault, Matthew, Nikiforow, Sarah, Weng, Wen-Kai, Specht, Jennifer, Dragovich, Tomislav, Vong, Judy, Mardiros, Armen, Liechty, Kirstin, Go, William Y, Welch, John, Ng, Eric W, Maus, Marcela, Maloney, David, Simeone, Diane M

Volltext

636 BASECAMP-1: A master prescreening study to identify patients with high-risk or metastatic solid tumors with HLA loss of heterozygosity (LOH) in preparation for Tmod CAR T-cell... von Simeone, Diane M, Randolph Hecht, J, Smith, Caleb, Fakih, Marwan, Welling, Theodore, Garon, Edward, Pia Morelli, M, Grierson, Patrick M, Kirtane, Kedar, Vu, Peter, Dahiya, Saurabh, Locke, Frederick L, Dorigo, Oliver, Park, Jong Chul, Jacobson, Caron, Specht, Jennifer, Dragovich, Tomislav, Lozac’hmeur, Ariane, Tebbets, Jessica, Ong, Gayanie, Go, William Y, Welch, John, Ng, Eric W, Maloney, David, Maus, Marcela, Molina, Julian

Volltext

A Phase I Pharmacokinetic and Pharmacodynamic Study of PX-12, a Novel Inhibitor of Thioredoxin-1, in Patients with Advanced Solid Tumors von RAMANATHAN, Ramesh K, KIRKPATRICK, D. Lynn, DRAGOVICH, Tomislav, BELANI, Chandra P, FRIEDLAND, David, GREEN, Sylvan B, CHOW, H-H. Sherry, CORDOVA, Catherine A, STRATTON, Steven P, SHARLOW, Elizabeth R, BAKER, Amanda

Volltext

Management strategies in pancreatic cancer von Campen, Christopher J, Dragovich, Tomislav, Baker, Amanda F

Volltext

Bortezomib With or Without Irinotecan in Relapsed or Refractory Colorectal Cancer: Results From a Randomized Phase II Study von KOZUCH, Peter S, ROCHA-LIMA, Cola Max, DRAGOVICH, Tomislav, HOCHSTER, Howard, O'NEIL, Bert H, ATIQ, Omar T, MARC PIPAS, J, RYAN, David P, HEINZ-JOSEFLENZ

Volltext

Phase I Trial of Imexon in Patients With Advanced Malignancy von DRAGOVICH, Tomislav, GORDON, Michael, DORR, Robert, MENDELSON, David, WONG, Lucas, MODIANO, Manuel, SHERRY CHOW, H.-H, SAMULITIS, Betty, O'DAY, Steven, GRENIER, Kathryn, HERSH, Evan

Volltext

Signal transduction pathways that regulate cell survival and cell death von Dragovich, T, Rudin, C M, Thompson, C B

Volltext

Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: Phase IB trial von DRAGOVICH, Tomislav, HUBERMAN, Mark, VON HOFF, Daniel D, ROWINSKY, Eric K, NADLER, Paul, WOOD, Debra, HAMILTON, Marta, HAGE, George, WOLF, Julie, PATNAIK, Amita

Volltext

Phase 3 PANOVA-3 study: Tumor treating fields (TTFields) therapy concomitant with gemcitabine and nab-paclitaxel (GnP) for front-line treatment of locally advanced pancreatic cance... von Babiker, Hani M., Macarulla, Teresa, Philip, Philip Agop, Becerra, Carlos Roberto, Dragovich, Tomislav, Picozzi, Vincent J.

Volltext